Upgrade to SI Premium - Free Trial

ImmunityBio (IBRX)

8.08 -0.11 (1.34%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26' September 1, 2026 9:07 AM - StreetInsider ImmunityBio names former World Bank president Jim Yong Kim as vice chairman August 10, 2026 9:01 AM - StreetInsider ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman August 10, 2026 9:00 AM - BizWire Form SCHEDULE 13D/A ImmunityBio, Inc. Filed by: Cambridge Equities, LP August 6, 2026 6:51 PM - SEC Filing Form 10-Q ImmunityBio, Inc. For: Jun 30 August 4, 2026 7:46 AM - SEC Filing ImmunityBio, Inc. (IBRX) Misses Q2 EPS by 14c August 4, 2026 7:38 AM - StreetInsider Form 8-K ImmunityBio, Inc. For: Aug 04 August 4, 2026 7:36 AM - SEC Filing ImmunityBio Reports Record Q2 2026 Net Product Revenue of $50.7 Million, Up 92% Year-Over-Year; First-Half Revenue Up 121% to $94.8 Million August 4, 2026 7:30 AM - BizWire Form 8-K ImmunityBio, Inc. For: Jul 29 July 30, 2026 5:20 PM - SEC Filing UAE approves ImmunityBio's Anktiva for bladder and lung cancer July 30, 2026 4:53 AM - StreetInsider ImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA® Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small July 29, 2026 6:45 PM - BizWire Form 4 ImmunityBio, Inc. For: Jul 02 Filed by: Cohen Cheryl July 6, 2026 8:26 PM - SEC Filing Form 4 ImmunityBio, Inc. For: Jul 01 Filed by: Selecky Christobel July 6, 2026 8:26 PM - SEC Filing Form 144 ImmunityBio, Inc. Filed by: Cohen Cheryl July 2, 2026 4:33 PM - SEC Filing Form 4 ImmunityBio, Inc. For: Jun 29 Filed by: Selecky Christobel July 1, 2026 5:05 PM - SEC Filing Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel July 1, 2026 4:30 PM - SEC Filing Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel June 30, 2026 4:36 PM - SEC Filing Form 144 ImmunityBio, Inc. Filed by: Selecky Christobel June 29, 2026 4:44 PM - SEC Filing Form 4 ImmunityBio, Inc. For: Jun 24 Filed by: Simon Barry J. June 26, 2026 9:02 PM - SEC Filing Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: BLASZYK MICHAEL D June 10, 2026 8:12 PM - SEC Filing Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: Wendel Bruce June 10, 2026 8:12 PM - SEC Filing Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: MAXWELL LINDA June 10, 2026 8:12 PM - SEC Filing Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: Clark Wesley June 10, 2026 8:11 PM - SEC Filing Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: Cohen Cheryl June 10, 2026 8:11 PM - SEC Filing Form 4 ImmunityBio, Inc. For: Jun 09 Filed by: Selecky Christobel June 10, 2026 8:11 PM - SEC Filing Form 8-K ImmunityBio, Inc. For: Jun 09 June 10, 2026 5:24 PM - SEC Filing Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet June 8, 2026 9:01 AM - Globe NewsWire Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet June 8, 2026 9:01 AM - StreetInsider Full Article List